A Vancomycin-Templated DNA-Encoded Library for Combating Drug-Resistant Bacteria.

Area of Science:

• Medicinal Chemistry
• Microbiology
• Drug Discovery

Background:

• The rise of multidrug-resistant bacterial infections poses a significant global health threat.
• Existing antibiotics are becoming less effective, necessitating the development of novel therapeutic strategies.

Purpose of the Study:

• To develop an innovative, large-scale screening strategy for novel antibacterial agents.
• To identify vancomycin derivatives with enhanced activity against resistant bacterial strains.

Main Methods:

• Utilized a whole bacteria-based DNA-encoded library (DEL) of vancomycin derivatives with peripheral modifications.
• Established a bacterial binding affinity assay to select high-affinity modification fragments.
• Resynthesized and evaluated the optimal vancomycin derivatives.

Main Results:

• The screening strategy successfully identified vancomycin derivatives with significantly enhanced antibacterial activity.
• Selected derivatives demonstrated potent efficacy against a range of resistant bacterial strains.
• Identified promising structural modifications for future vancomycin derivatization.

Conclusions:

• The study presents a novel natural product-templated DEL approach for antibiotic discovery.
• Bacterial affinity screening is an effective method for identifying potent antibacterial agents.
• This work contributes to the ongoing fight against drug-resistant bacteria.